Starling Oncology, Inc. (DFPH) Total assets 2020–2025
Starling Oncology, Inc. (DFPH) total assets at each fiscal year-end, per SEC filings.
$164.7MFY2025 · since FY2020: $65.7M → $164.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $164.7M | -4.7% |
| FY2024 | $172.7M | -17.5% |
| FY2023 | $209.2M | -20.0% |
| FY2022 | $261.7M | +28.6% |
| FY2021 | $203.4M | +209.7% |
| FY2020 | $65.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Operating cash flowDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →